Cargando…

Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo

Esophageal squamous cell carcinoma (ESCC) accounts for almost 90% of esophageal cancer cases and is the sixth most common cause of cancer-associated mortality worldwide. Cisplatin is the standard therapeutic reagent for ESCC; however, chemoresistance frequently occurs after a few weeks, which leads...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiansong, Ji, Huaijun, Zhu, Qiang, Yu, Xinshuang, Du, Juan, Jiang, Zhongmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507449/ https://www.ncbi.nlm.nih.gov/pubmed/31186712 http://dx.doi.org/10.3892/ol.2019.10160

Ejemplares similares

Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma
por: Ji, Huaijun, et al.
Publicado: (2017)

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer
por: Zhang, Xiao-Wei, et al.
Publicado: (2010)

Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma
por: Lu, You-Wei, et al.
Publicado: (2010)

Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
por: Yin, Shuying, et al.
Publicado: (2020)

Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma
por: Zhang, Si, et al.
Publicado: (2014)

Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
por: Ji, Yubin, et al.
Publicado: (2019)

The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.
por: Smyth, M. J., et al.
Publicado: (1987)

Effects of ursolic and oleanolic on SK-MEL-2 melanoma cells: In vitro and in vivo assays
por: Caunii, Angela, et al.
Publicado: (2017)

MEL-18, a tumor suppressor for aggressive breast cancer
por: Lee, Jeong-Yeon, et al.
Publicado: (2015)

Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
por: Zhao, Lili, et al.
Publicado: (2022)

Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro
por: Li, Qinghua, et al.
Publicado: (2016)

TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro
por: Menke, Christina, et al.
Publicado: (2011)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Comparative study of antidiabetic, bactericidal, and antitumor activities of MEL@AgNPs, MEL@ZnONPs, and Ag–ZnO/MEL/GA nanocomposites prepared by using MEL and gum arabic
por: Bakur, Abdelmoneim, et al.
Publicado: (2019)

Mel – Personal Reminiscence(†)
por: Taeusch, H. William
Publicado: (2014)

Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Yu, Xinshuang, et al.
Publicado: (2016)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: WANG, TING, et al.
Publicado: (2015)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: Wang, Ting, et al.
Publicado: (2023)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

Retraction: Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Publicado: (2022)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation
por: Li, Bo, et al.
Publicado: (2021)

In vivo and in vitro characterizations of melibiose permease (MelB) conformation-dependent nanobodies reveal sugar-binding mechanisms
por: Katsube, Satoshi, et al.
Publicado: (2023)

miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
por: Tian, Hang, et al.
Publicado: (2022)

MEL scripting for Maya animators
por: Wilkins, Mark R, et al.
Publicado: (2005)

Professional MEL solutions for production
por: Mannens, Kevin, et al.
Publicado: (2009)

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
por: Jian, Jie, et al.
Publicado: (2020)

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
por: Choy, Bonnie, et al.
Publicado: (2012)

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin
por: Wang, Feng, et al.
Publicado: (2017)

Autoregulation of the Escherichia coli melR promoter: repression involves four molecules of MelR
por: Samarasinghe, Shivanthi, et al.
Publicado: (2008)

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)

In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity
por: Yao, Qing, et al.
Publicado: (2019)

ERK Activation by Fucoidan Leads to Inhibition of Melanogenesis in Mel-Ab Cells
por: Song, Yu Seok, et al.
Publicado: (2015)

CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells
por: Akhtar, Javed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nqh88d184fvu2hkrnmjsfsgdqu